Text Size
9 studies found for:    aegerion

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Active, not recruiting Long Term, Follow-on Study of Lomitapide in Patients With Homozygous Familial Hypercholesterolemia
Condition: Familial Hypercholesterolemia
Intervention: Drug: lomitapide
2 Completed
Has Results 		A Safety and Efficacy Study of AEGR-733 to Treat Homozygous Familial Hypercholesterolemia (FH)
Condition: Homozygous Familial Hypercholesterolemia
Intervention: Drug: AEGR-733
3 Completed
Has Results 		Evaluate Low Doses of AEGR-733 on Hepatic Fat Accumulation by MRS
Condition: Hyperlipidemia
Interventions: Drug: AEGR-733;   Drug: placebo;   Drug: AEGR-733 and atorvastatin;   Drug: AEGR-733 and fenofibrate;   Drug: AEGR-733 and ezetimibe
4 Completed Pharmacokinetic Drug Interactions of AEGR-733 on Lipid-lowering Agents
Condition: Healthy
Interventions: Drug: atorvastatin;   Drug: simvastatin;   Drug: ezetimibe;   Drug: fenofibrate;   Drug: dextromethorphan;   Drug: Extended Release Niacin
5 Completed
Has Results 		Safety, Tolerability and Efficacy of Microsomal Triglyceride Protein (MTP) Inhibitor
Condition: Homozygous Familial Hypercholesterolemia
Intervention: Drug: Lomitapide
6 Completed
Has Results 		AEGR-733 and Atorvastatin 20 mg vs. Monotherapy in Moderate Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: Atorvastatin 20 mg;   Drug: AEGR-733 5 mg;   Drug: AEGR-733 10 mg;   Drug: Placebo;   Drug: AEGR-733 5 mg + atorvastatin 20 mg;   Drug: AEGR-733 10 mg + atorvastatin 20 mg
7 Completed
Has Results 		Evaluate Safety and Efficacy of AEGR-733 and Atorvastatin vs Atorvastatin Monotherapy in Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: Atorvastatin;   Drug: AEGR-733
8 Recruiting Phase I Study of the Safety, Tolerability, PK & PD of Lomitapide in Japanese and Caucasian Subjects With Elevated LDL-C
Condition: Healthy Volunteer
Intervention: Drug: lomitapide
9 Completed The Safety & Efficacy of Combination BMS-201038 (AEGR-733) & Ezetimibe vs. Monotherapy in Moderate Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: BMS-201038 (AEGR-733);   Drug: Ezetimibe
To Top

† Indicates status has not been verified in more than two years